RxDoctor Payments Data

Ramesh Gupta

Bakersfield, CANPI 1174586531

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Medtronic at 57.3% of the total.

$278in general payments, 2019–2025

Across 10 payments — averaging $27.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$159
  • Johnson & Johnson$85
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$22
  • Takeda Pharmaceuticals U.S.A., Inc.$11
$514,851in research payments, 2019–2025

Across 87 payments — averaging $5917.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$515K

What the payments were for

  • Food & beverage$278100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →